Related Information

About Us

Did you know?

  • In exchange for a two or three-year (for Intramural General Research) commitment to your research career, NIH will repay up to $35,000 per year of your qualified educational debt. See NIH Loan Repayment Programs

Research in NIAMS Labs

Updated October 28, 2014

Photo of Dr. John O'Shea, NIAMS Scientific Director

Welcome to NIAMS Labs from Dr. John O'Shea, NIAMS Scientific Director

As you will see, our program comprises scientists, physicians, nurses, trainees and administrators who work together to solve basic scientific problems and devise new treatments for arthritis, musculoskeletal and skin diseases.

Photo of Dr. John O'Shea

NIAMS' Scientific Director Elected to Institute of Medicine

John J. O’Shea, M.D., has been elected to membership in the Institute of Medicine (IOM) of the National Academy of Sciences. He has "advanced the field of immunology by translating his discoveries into approaches that improve human health," says NIAMS Director Stephen I. Katz, M.D., Ph.D.

Photos of Drs. Laurence, Kanno and O'Shea.

Three NIAMS Researchers Named "Most Influential"

Drs. John O’Shea, Yuka Kanno and Arian Laurence have been included by Thomson Reuters in The World’s Most Influential Scientific Minds 2014 report, in immunology, joining the ranks of researchers who are "publishing work that their peers recognize as vital to the advancement of their science" and "on the cutting edge of their fields."

Schematic of the increased neutrophil extracellular trap (NET) formation in SLE

The Kaplan Lab Shows an Additional Proatherogenic Mechanism in SLE

This work identifies neutrophils as important inducers of lipoprotein oxidation, suggesting an additional mechanism for premature vascular disease in autoimmune disorders.

The Drake Medal

Dr. O'Shea Receives the Drake Medal

Dr. O'Shea, NIAMS scientific director, has been awarded the 2014 Drake Medal from the University of Cincinnati for outstanding and unique contributions to medical education, scholarship and research.